Cargando…

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility

Inflammatory bowel diseases are chronic diseases affecting the gastrointestinal tract, whose major forms are represented by Crohn's disease (CD) and ulcerative colitis (UC). Their etiology is still unclear, although several factors have been identified as major determinants for induction or rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scaldaferri, Franco, Gerardi, Viviana, Lopetuso, Loris Riccardo, Del Zompo, Fabio, Mangiola, Francesca, Boškoski, Ivo, Bruno, Giovanni, Petito, Valentina, Laterza, Lucrezia, Cammarota, Giovanni, Gaetani, Eleonora, Sgambato, Alessandro, Gasbarrini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749555/ https://www.ncbi.nlm.nih.gov/pubmed/23991417 http://dx.doi.org/10.1155/2013/435268

Ejemplares similares

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
por: Gaetani, Eleonora, et al.
Publicado: (2018)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide
por: Scaldaferri, F., et al.
Publicado: (2017)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis
por: Di Vincenzo, Federica, et al.
Publicado: (2022)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
por: Piscaglia, Anna Chiara, et al.
Publicado: (2016)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
por: Pizzoferrato, Marco, et al.
Publicado: (2019)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease
por: Laterza, Lucrezia, et al.
Publicado: (2016)

Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
por: Graziani, Cristina, et al.
Publicado: (2022)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2020)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes
por: Boškoski, Ivo, et al.
Publicado: (2020)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
por: Martyniak, Adrian, et al.
Publicado: (2021)

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey
por: Marasco, Giovanni, et al.
Publicado: (2020)

Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88hhn2a5dqstrh1t4lspjlo0u6